Talis Biomedical Corporat... (TLIS)
1.74
0.14 (8.75%)
At close: Mar 21, 2025, 9:30 AM
1.74
0.00%
After-hours: Mar 27, 2025, 04:00 PM EDT
8.75% (1D)
| Bid | 1.56 |
| Market Cap | 3.17M |
| Revenue (ttm) | 300.07K |
| Net Income (ttm) | -51.04M |
| EPS (ttm) | -28.02 |
| PE Ratio (ttm) | -0.06 |
| Forward PE | -0.07 |
| Analyst | n/a |
| Ask | 1.74 |
| Volume | 36 |
| Avg. Volume (20D) | 1,723 |
| Open | 1.60 |
| Previous Close | 1.60 |
| Day's Range | 1.60 - 1.74 |
| 52-Week Range | 1.37 - 9.60 |
| Beta | 1.47 |
About TLIS
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's ...
Industry Medical - Devices
Sector Healthcare
IPO Date Feb 12, 2021
Employees 99
Stock Exchange NASDAQ
Ticker Symbol TLIS
Website https://talisbio.com
7 months ago
-49.33%
Talis Biomedical shares are trading lower after th...
Unlock content with
Pro Subscription
3 months ago · https://www.marketscreener.com
North American Morning Briefing : Global Ad Shares -2-Lundin Mining Announces Sale to Boliden of its Neves-Corvo operation in Portugal and Zinkgruvan operation in Sweden for Up to $1.52 Billion: Lundin To Receive Upfront Cash Consideration of $1.37B Upon...